Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity

Cellular and Molecular Life Sciences

Volumn 63, Issue 19-20, 2006, Pages 2405-2414

  Wang, J ^a   Shafqat, J ^a   Hall, K ^a   Stahlberg M ^a   Wivall Helleryd, I L ^a   Bouzakri, K ^a   Zierath, J R ^a   Brismar, K ^a   Jornvall H ^a   Lewitt, M S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Azurocidin heparin binding protein CAP37; Catabolism; IGF binding protein 1; Insulin like growth factor; Proteolysis; Skeletal muscle

Indexed keywords

APROTININ; AZUROCIDIN; BENZAMIDINE; CHYMOSTATIN; KALLIKREIN INHIBITOR; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 1;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; BLOOD PROTEINS; CARRIER PROTEINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEIN ISOFORMS; SOMATOMEDINS;

EID: 33750526241     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6248-7     Document Type: Article

References (38)

1. Firth, S. M. and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854.
2. Lewitt, M. S. (1994) Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diab. Res. Clin. Pract. 23, 3-15.
3. Westwood, M., Gibson, J. M. and White, A. (1997) Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma. Endocrinology 138, 1130-1136.
4. Jones, J. I., D'Ercole, A. J., Camacho-Hubner, C. and Clemmons, D. R. (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA 88, 7481-7485.
5. Lang, C. H., Nystrom, G. J. and Frost, R. A. (1999) Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species. Am. J. Physiol. 276, G719-G727.
6. Lewitt, M. S. (2001) Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 282, 1126-1131.
7. Lee, P. D. K., Giudice, L. C., Conover, C. A. and Powell, D. R. (1997) Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exp. Biol. Med. 216, 319-357.
8. Mesotten, D., Delhanty, P. J., Vanderhoydonc, F., Hardman, K. V., Weekers, F., Baxter, R. C. and Van den Berghe, G. (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J. Clin. Endocrinol. Metab. 87, 5516-5523.
9. de Groof, F., Joosten, K. F., Janssen, J. A., de Kleijn, E. D., Hazelzet, J. A., Hop, W. C., Uitterlinden, P., van Doorn, J. and Hokken-Koelega, A. C. (2002) Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J. Clin. Endocrinol. Metab. 87, 3118-3124.
10. Frost, R. A. and Lang, C. H. (1999) Differential effects of insulin-like growth factor I (IGF-I) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells. Endocrinology 140, 3962-3970.
11. Póvoa, G., Enberg, G., Jörnvall, H. and Hall, K. (1984) Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur. J. Biochem. 144, 199-204.
12. Clay Bunn, R. and Fowlkes, J. L. (2003) Insulin-like growth factor binding protein proteolysis. Trends Endocrinol. Metab. 14, 176-181.
13. Gibson, J. M., Aplin, J. D., White, A. and Westwood, M. (2001) Regulation of IGF bioavailability in pregnancy. Mol. Hum. Reprod. 7, 79-87.
14. Kuehl, W. M. and Bergsagel, P. L. (2002) Multiple myeloma: evolving genetic events and host interactions. Nat. Rev. Cancer 2, 175-187.
15. Bayes-Genis, A., Conover, C. A. and Schwartz, R. S. (2000) The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ. Res. 86, 125-130.
16. 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90, 10553-10557.
17. Bayes-Genis, A., Conover, C. A., Overgaard, M. T., Bailey, K. R., Christiansen, M., Holmes, D. R. Jr, Virmani, R., Oxvig, C. and Schwartz, R. S. (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 345, 1022-1029.
18. Norin, A., Shafqat, J., El-Ahmad, M., Alvelius, G., Cederlund, E., Hjelmqvist, L. and Jörnvall, H. (2004) Class III alcohol dehydrogenase: consistent pattern complemented with the mushroom enzyme. FEBS Lett. 559, 27-32.
19. Roblick, U. J., Hirschberg, D., Habermann, J. K., Palmberg, C., Becker, S., Kruger, S., Gustafsson, M., Bruch, H. P., Franzen, B., Ried, T., Bergmann, T., Auer, G. and Jörnvall, H. (2004) Sequential proteome alterations during genesis and progression of colon cancer. Cell. Mol. Life Sci. 61, 1246-1255.
20. Bouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J. P., Laville, M., Le Marchand-Brustel, Y., Tanti, J. F. and Vidal, H. (2003) Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52, 1319-1325.
21. Bouzakri, K., Roques, M., Debard, C., Berbe, V., Rieusset, J., Laville, M. and Vidal, H. (2004) WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients. Diabetologia 47, 1314-1323.
22. Tanaka, T. and Yada, R. Y. (2001) N-terminal portion acts as an initiator of the inactivation of pepsin at neutral pH. Protein Eng. 14, 669-674.
23. Luthman, H., Söderling-Barros, J., Persson, B., Engberg, C., Stern, I., Lake, M., Franzén, S.-Å., Israelsson, M., Råden, B., Lindgren, B., Hjelmqvist, L., Enerbäck, S., Carlsson, P., Bjursell, G., Póvoa, G., Hall, K. and Jörnvall, H. (1989) Human insulin-like growth-factor-binding protein. Low-molecular-mass form: protein sequence and cDNA cloning. Eur. J. Biochem. 180, 259-265.
24. Kiczak, L., Koscielska, K., Otlewski, J., Czerwinski, M. and Dadlez, M. (1999) Phage display selection of P1 mutants of BPTI directed against five different serine proteinases. Biol. Chem. 380, 101-105.
25. Hwa, V., Oh, Y. and Rosenfeld, R. G. (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761-787.
26. Jones, J. I., Busby, W. H., Wright, G., Smith, C. E., Kimack, N. M. and Clemmons, D. R. (1993) Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. J. Biol. Chem. 268, 1125-1131.
27. Sala, A., Capaldi, S., Campagnoli, M., Faggion, B., Labo, S., Perduca, M., Romano, A., Carrizo, M. E., Valli, M., Visai, L., Minchiotti, L., Galliano, M. and Monaco, H. L. (2005) Structure and properties of the C-terminal domain of insulin-like growth factor binding protein-1 isolated from human amniotic fluid. J. Biol. Chem. 280, 29812-29819.
28. Olczak, M. and Watorek, W. (2002) Structural analysis of N-glycans from human neutrophil azurocidin. Biochem. Biophys. Res. Commun. 293, 213-219.
29. Wilde, C. G., Snable, J. L., Griffith, J. E. and Scott, R. W. (1990) Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase. J. Biol. Chem. 265, 2038-2041.
30. Campanelli, D., Detmers, P. A., Nathan, C. F. and Gabay, J. E. (1990) Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85, 904-915.
31. Pereira, H. A., Spitznagel, J. K., Pohl, J., Wilson, D. E., Morgan, J., Palings, I. and Larrick, J. W. (1990) CAP 37, a 37 kDa human neutrophil granule cationic protein shares homology with inflammatory proteinases. Life Sci. 46, 189-196.
32. Gibson, T. L. B. and Cohen, P. (1999) Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm. IGF Res. 9, 241-253.
33. Watorek, W. (2003) Azurocidin: inactive serine proteinase homolog acting as a multifunctional inflammatory mediator. Acta Biochim. Pol. 50, 743-752.
34. Okuyama, Y., Cho, J. H., Nakajima, Y., Homma, K., Sekimizu, K. and Natori, S. (2004) Binding between azurocidin and calreticulin: its involvement in the activation of peripheral monocytes. J. Biochem. (Tokyo) 135, 171-177.
35. Borregaard, N. and Cowland, J. B. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89, 3503-3521.
36. Lee, T. D., Gonzalez, M. L., Kumar, P., Chary-Reddy, S., Grammas, P. and Pereira, H. A. (2002) CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am. J. Pathol. 160, 841-848.
37. Frost, R. A., Bereket, A., Wilson, T. A., Wojnar, M. M., Lang, C. H. and Gelato, M. C. (1994) Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and severe trauma. J. Clin. Endocrinol. Metab. 78, 1533-1535.
38. Fan, J., Molina, P. E., Gelato, M. C. and Lang, C. H. (1994) Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134, 1685-1692.